{"id":"sublingual-nitroglycerine","safety":{"commonSideEffects":[{"rate":"10-30%","effect":"Headache"},{"rate":"5-15%","effect":"Dizziness"},{"rate":"5-15%","effect":"Flushing"},{"rate":"5-15%","effect":"Hypotension"},{"rate":"5-15%","effect":"Tachycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to vasodilation and a decrease in cardiac workload, resulting in reduced myocardial oxygen demand. Nitroglycerine is a nitrate ester prodrug that is converted to nitric oxide in the body, which then activates guanylate cyclase and increases cyclic GMP levels, leading to smooth muscle relaxation.","oneSentence":"Sublingual nitroglycerine works by releasing nitric oxide, which relaxes vascular smooth muscle and reduces blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:42.180Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"},{"name":"Atrial fibrillation for rate control"}]},"trialDetails":[{"nctId":"NCT07431294","phase":"PHASE1","title":"A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"Bayer","startDate":"2026-04-07","conditions":"Stable Coronary Artery Disease","enrollment":36},{"nctId":"NCT02425566","phase":"PHASE1","title":"Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2015-04","conditions":"Hypertension","enrollment":12},{"nctId":"NCT06956924","phase":"NA","title":"Abdominal Aortic Calcium and CAD-RADS 2.0","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-06-01","conditions":"Coronary Artery Disease (CAD)","enrollment":68},{"nctId":"NCT03974412","phase":"NA","title":"Syncope Trial to Understand Tilt Testing Early or Recorders Study","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2019-05-28","conditions":"Syncope","enrollment":40},{"nctId":"NCT06823843","phase":"PHASE4","title":"The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow","status":"COMPLETED","sponsor":"VZW Cardiovascular Research Center Aalst","startDate":"2024-07-01","conditions":"Coronary Arterial Disease (CAD), Angina (Stable)","enrollment":40},{"nctId":"NCT05393882","phase":"","title":"Impact of Cholesterol Level on Long-term Coronary Bypass Graft Patency","status":"WITHDRAWN","sponsor":"Chinese University of Hong Kong","startDate":"2025-09","conditions":"Coronary Artery Disease, Bypass Graft Stenosis, Dyslipidemias","enrollment":""},{"nctId":"NCT05776810","phase":"NA","title":"Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2023-05-01","conditions":"Syncope","enrollment":144},{"nctId":"NCT05635851","phase":"PHASE2","title":"NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI","status":"NOT_YET_RECRUITING","sponsor":"Simon Fraser University","startDate":"2025-09","conditions":"Spinal Cord Injuries, Autonomic Dysreflexia","enrollment":26},{"nctId":"NCT03689946","phase":"PHASE3","title":"Effect of Evolocumab on Coronary Atherosclerosis","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2019-03-19","conditions":"Cardiovascular Disease, Hyperlipidemia","enrollment":55},{"nctId":"NCT06265415","phase":"NA","title":"Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-03-30","conditions":"Severe Preeclampsia","enrollment":60},{"nctId":"NCT04221594","phase":"","title":"Quantification of Myocardial Blood Flow Using Dynamic PET/CTA Fused Imagery","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-11-01","conditions":"Coronary Artery Disease","enrollment":68},{"nctId":"NCT05907655","phase":"","title":"Study of the Glymphatic System in Migraine","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2023-04-30","conditions":"Migraine","enrollment":50},{"nctId":"NCT03305848","phase":"PHASE4","title":"Esophageal Food Impaction","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2017-08-25","conditions":"Esophageal Food Bolus Obstruction","enrollment":20},{"nctId":"NCT03014791","phase":"","title":"Influence of Age, Weight and Ethnic Background on Blood Pressure","status":"UNKNOWN","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-02-21","conditions":"Cardiovascular Diseases, Vascular Diseases, Hypertension","enrollment":500},{"nctId":"NCT01516346","phase":"PHASE2","title":"Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Corporal Michael J. Crescenz VA Medical Center","startDate":"2012-01","conditions":"Heart Failure, Congestive Heart Failure","enrollment":44},{"nctId":"NCT03338504","phase":"","title":"Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2017-10-23","conditions":"Myocardial Infarction, Acute, Myocardial Ischemia, Myocardial Injury","enrollment":100},{"nctId":"NCT01742702","phase":"","title":"HaemoDYNAMICs in Primary and Secondary Hypertension","status":"UNKNOWN","sponsor":"Tampere University","startDate":"2006-05-25","conditions":"Primary Hypertension, Secondary Hypertension, Aortic Stenosis","enrollment":2000},{"nctId":"NCT04484298","phase":"NA","title":"Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2019-01-02","conditions":"Heart Failure","enrollment":100},{"nctId":"NCT01811693","phase":"PHASE2","title":"Field Administration of Stroke Therapy-Blood Pressure Lowering","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2013-04","conditions":"Intracerebral Hemorrhage, Ischemic Stroke","enrollment":4},{"nctId":"NCT04556942","phase":"NA","title":"Improvement of Cardiovascular Function After Bronchoscopic Lung Volume Reduction Using Endobronchial Valves","status":"UNKNOWN","sponsor":"Daniel Franzen","startDate":"2020-06-05","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":40},{"nctId":"NCT00512759","phase":"PHASE4","title":"Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2007-12-10","conditions":"Acute Heart Failure","enrollment":781},{"nctId":"NCT02961946","phase":"PHASE4","title":"Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-03-15","conditions":"Coronary Artery Disease","enrollment":198},{"nctId":"NCT02906553","phase":"NA","title":"The Role of Nitric Oxide in Cognition in Schizophrenia","status":"COMPLETED","sponsor":"King's College London","startDate":"2016-09","conditions":"Schizophrenia, Psychotic Disorders","enrollment":19},{"nctId":"NCT04008732","phase":"PHASE1","title":"Evaluating MED2005 & Nitrostat Bioavailability","status":"COMPLETED","sponsor":"Futura Medical Developments Ltd.","startDate":"2017-11-15","conditions":"Erectile Dysfunction","enrollment":40},{"nctId":"NCT01167582","phase":"PHASE3","title":"Myocardial Ischemia and Transfusion Pilot","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2009-09","conditions":"Myocardial Infarction, Unstable Angina, Coronary Artery Disease","enrollment":110},{"nctId":"NCT03756116","phase":"NA","title":"Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide","status":"UNKNOWN","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2018-10-01","conditions":"Post-ERCP Acute Pancreatitis, Epinephrine","enrollment":2000},{"nctId":"NCT03404037","phase":"","title":"Serum Endostatin Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2017-03-02","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease, Coronary Arteriosclerosis","enrollment":110},{"nctId":"NCT02327793","phase":"PHASE2","title":"Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2009-06","conditions":"Stroke, Acute","enrollment":65},{"nctId":"NCT01715220","phase":"PHASE2","title":"Treatment of Suspected Cholelithiasis With Nitroglycerin","status":"UNKNOWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2014-10","conditions":"COLIC, BILIARY TRACT DISEASES","enrollment":62},{"nctId":"NCT00759707","phase":"NA","title":"Endothelial Function in Lower Extremity Bypass Grafts","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2006-04","conditions":"Peripheral Arterial Disease","enrollment":19},{"nctId":"NCT01703156","phase":"NA","title":"Low Risk Acute Coronary Syndrome","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2009-05","conditions":"Low Risk Acute Coronary Syndrome","enrollment":70},{"nctId":"NCT00554853","phase":"PHASE3","title":"PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2007-11","conditions":"Rheumatoid Arthritis","enrollment":143},{"nctId":"NCT01387672","phase":"PHASE3","title":"Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2011-09","conditions":"Osteoporosis","enrollment":265},{"nctId":"NCT00583388","phase":"","title":"The Role of L-arginine in the Endothelial Dysfunction","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2010-06","conditions":"Healthy","enrollment":""},{"nctId":"NCT01425359","phase":"PHASE4","title":"Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2011-09","conditions":"Angina Pectoris, Coronary Artery Disease, Type 2 Diabetes Mellitus","enrollment":949},{"nctId":"NCT01104597","phase":"NA","title":"Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians","status":"WITHDRAWN","sponsor":"Northwell Health","startDate":"2010-04","conditions":"Healthy","enrollment":""},{"nctId":"NCT00586261","phase":"NA","title":"Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2006-03","conditions":"Chronic Kidney Disease","enrollment":36},{"nctId":"NCT01097551","phase":"","title":"Endothelial Dysfunction and Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-01","conditions":"Type 1 Diabetes Mellitus","enrollment":38},{"nctId":"NCT01616485","phase":"PHASE1","title":"Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2004-03","conditions":"Erectile Dysfunction","enrollment":106},{"nctId":"NCT01502943","phase":"PHASE4","title":"Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index","status":"COMPLETED","sponsor":"Liaoning University of Traditional Chinese Medicine","startDate":"2011-05","conditions":"Coronary Heart Disease, Stable Angina Pectoris","enrollment":480},{"nctId":"NCT00431691","phase":"PHASE4","title":"Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2006-09","conditions":"Retina, Regional Blood Flow, Endotoxin, Escherichia Coli","enrollment":22},{"nctId":"NCT00479908","phase":"PHASE4","title":"Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With Angina","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2004-01","conditions":"Angina Pectoris","enrollment":20}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BLOOD POTASSIUM INCREASED"},{"count":1,"reaction":"DECREASED APPETITE"},{"count":1,"reaction":"FATIGUE"},{"count":1,"reaction":"HEADACHE"},{"count":1,"reaction":"HEPATITIS CHOLESTATIC"},{"count":1,"reaction":"LEFT ATRIAL DILATATION"},{"count":1,"reaction":"LIVER FUNCTION TEST ABNORMAL"},{"count":1,"reaction":"MYOCARDIAL ISCHAEMIA"},{"count":1,"reaction":"PULMONARY VALVE INCOMPETENCE"},{"count":1,"reaction":"PYREXIA"}],"_approvalHistory":[],"publicationCount":87,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Nitrolingual"],"phase":"phase_3","status":"active","brandName":"sublingual nitroglycerine","genericName":"sublingual nitroglycerine","companyName":"United States Naval Medical Center, San Diego","companyId":"united-states-naval-medical-center-san-diego","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sublingual nitroglycerine works by releasing nitric oxide, which relaxes vascular smooth muscle and reduces blood pressure. Used for Angina pectoris, Atrial fibrillation for rate control.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}